Ethical challenges with smartwatch-based screening for atrial fibrillation: putting users at risk for marketing purposes?
Frontiers in Cardiovascular Medicine ; 7 (2021). - Art.-Nr. 615927. - eISSN 2297-055X
Link to original publicationhttps://dx.doi.org/10.3389/fcvm.2020.615927
InstitutionsInstitut für Geschichte, Theorie und Ethik der Medizin
Document versionpublished version (publisher's PDF)
Background: Atrial fibrillation is the most common persistent arrhythmia. It is associated with increased mortality and morbidity such as stroke. The early detection of atrial fibrillation can significantly reduce the risk of stroke through preventive anticoagulation. Smartwatches offer the opportunity to screen for atrial fibrillation in the general population. This paper aims to analyze the ethical challenges associated with screening for atrial fibrillation using smartwatches. Methods: This is an ethical analysis. The methodology is based on the principle-orientated approach of Beauchamp and Childress. The principles of beneficence, non-maleficence, justice, and autonomy have to be guaranteed given the influence of private companies, privacy protection, liability and doctor-patient-relationship. The work is based on a systematic literature research. Results: There is currently no evidence that screening for atrial fibrillation with smartwatches improves the outcome and reduces the number of adverse events. The high number of false-positive results can lead to harm. The principle of non-maleficence is violated. The over-reliance on and the lack of adequate education by smartwatches can worsen the doctor-patient relationship. However, the relationship can also be improved by the proactive participation of the patient, which leads to greater autonomy, compliance and in the end beneficence. Since smartwatches are consumer goods, there is a risk for greater disparities in the poor and rich population. There is also a risk of discrimination against ethnic minorities due to underrepresentation in training data and study cohorts. The principle of justice is violated. The storage of sensitive medical data by private companies also raises many ethical and legal concerns. Conclusion: This analysis has shown that the use of smartwatches to detect atrial fibrillation is currently in an ethical perspective problematic. The lack of evidence and the high number of false-positive results can lead to harm. As smartwatches provide only little information about the possible consequences, informed consent cannot be assumed. Ethical implementation could be archived if doctors provide smartwatches to patients who have been shown to benefit from them. The implementation and education should be managed by the doctor.
Open-Access-Förderung durch die Medizinische Fakultät der Universität Ulm
Subject headings[GND]: Vorhofflimmern | Smartwatch | Künstliche Intelligenz | Medizinische Ethik
[MeSH]: Atrial fibrillation | Early diagnosis | Early medical intervention | Artificial intelligence | Personal autonomy | Ethics, Medical
[Free subject headings]: Wearable | Justice
[DDC subject group]: DDC 610 / Medicine & health
LicenseCC BY 4.0 International
MetadataShow full item record
DOI & citation
Please use this identifier to cite or link to this item: http://dx.doi.org/10.18725/OPARU-34400